Skip to content

Validation of Nexfin Cardiac Output in Elderly Patients With Hip Fracture

Validation of the Nexfin Non-invasive Cardiac Output Monitor in Patients Undergoing Hip Fracture Repair

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01474824
Enrollment
6
Registered
2011-11-18
Start date
2013-01-31
Completion date
2013-10-31
Last updated
2014-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Hip Fractures

Keywords

Cardiac output, Stroke volume

Brief summary

Measurement of how much blood the heart pumps may be useful in guiding how much intravenous fluid to give patients during surgery. The current monitors either require special drips (arterial and/or central lines) or a probe inserted into the oesophagus (food pipe) which may limit their use. Newer monitors are available which are completely non-invasive and seem to work well in younger patients. Patients with hip fracture are elderly and frail. The investigators wish to see whether the newer non-invasive monitor works well enough compared to the current monitors in this group of patients. If it does this may allow more of these patients to be monitored in this way.

Detailed description

The investigators wish to compare the accuracy of the newer, non-invasive monitor (Nexfin) against a more established minimally invasive monitor (LiDCO). The LiDCO has a calibration system which allows the absolute accuracy of the Nexfin to be established.

Interventions

None listed

Sponsors

Nottingham University Hospitals NHS Trust
CollaboratorOTHER
Brighton and Sussex University Hospitals NHS Trust
CollaboratorOTHER
University of Nottingham
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
80 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Aged over 80 * Able to give their own informed consent

Exclusion criteria

* Severe valvular heart disease * Taking lithium

Design outcomes

Primary

MeasureTime frameDescription
Bias and limits of agreement of Nexfin recorded cardiac output compared with LiDCOplusDuring anaesthesia period of surgery - measurements will be complete within 30 minutes of starting anaesthesiaAnalysis of agreement between Nexfin cardiac output and the calibrated cardiac output measured by LiDCOplus

Secondary

MeasureTime frameDescription
Bias and limits of agreement for change in cardiac output measured by Nexfin compared with LiDCODuring anaesthesia period of surgery - measurements will be complete within 30 minutes of starting anaesthesiaComparison of relative changes in cardiac output recorded by Nexfin and LiDCO in response to intra-anaesthesia / intra-operative events (fluid administration, drug administration)
Utility of Nexfin monitorIntra-operative - average duration about 1 hourProportion of time during anaesthesia and surgery when a valid signal is obtained from the Nexfin device.
Adverse events associated with Nexfin monitorIntra-operative - average duration about one hourRecording of adverse events associated with use of the Nexfin monitor

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026